Saturday 17 October 2026 Export FDMT’s income statement to Excel — free account

4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $85.2 million, up 230,194.6% from fiscal 2024. In the quarter to June 2026, revenue grew 25,106.7%, EPS fell 6.12% and free cash flow fell 61.3%, each against the same quarter a year earlier.

12.14 0.73 −5.67%

Follow FDMT

Alert me

Market cap: $711.0M
P/E: 0.0×
Fwd P/E: −2.2×
Dividend yield: —
F-score: 4/9
Altman Z: 2.50
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	4	3	2
ROE Full definition →		(45.38%)	(27.57%)	(34.92%)	(43.25%)
ROA Full definition →		(40.70%)	(24.86%)	(31.28%)	(37.09%)
ROIC Full definition →		(225.26%)	(96.80%)	(184.13%)	(186.91%)
Return on Tangible Assets Full definition →		(71.78%)	(36.49%)	(42.84%)	(51.54%)
Average Days of Receivables Full definition →		0.00	0.00	0.00	18.29
Free Cash Flow per Share Full definition →		(3.30)	(1.89)	(1.90)	(2.22)
Free Cash Flow Full definition →		(185.05)	(109.62)	(129.34)	(155.96)
Capital Expenditures Full definition →		(1.55)	(0.54)	0.11	0.11
Other line items
Cash ROIC Full definition →		(27.45%)	(12.07%)	(15.35%)	(19.78%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	31.57
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		150,977.50%	229.67%	249.29%	261.18%
Selling, General and Administrative Expense of Revenue Full definition →		41,105.00%	57.58%	54.18%	53.06%
Share Based Compensation of Revenue Full definition →		20,034.17%	25.84%	22.08%	22.18%
Operating CF/Net income Full definition →		0.88	0.78	0.80	0.87
Depreciation/Fixed assets Full definition →		(0.05)	0.00	0.02	0.05
Capex/Depreciation Full definition →		1.80	13.40	0.34	0.18
Revenue per Share Full definition →		0.00	1.47	1.30	1.31
Operating CF per Share Full definition →		(3.27)	(1.88)	(1.90)	(2.22)
Capex per Share Full definition →		(0.03)	(0.01)	0.00	0.00
Capex to Sales Full definition →		12.96	0.01	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly